Kentucky Medicaid and GLP-1s
Kentucky's GLP-1 criteria open with a limit on changing your mind. Two brand switches a year, then you stay put. Everything else on the page is diabetes: a confirmed type 2 diagnosis, an A1c to match, a thyroid-cancer history check, and a footnote under each block saying drugs used for weight loss are excluded. The state's drug list names no weight-management GLP-1 anywhere.
What changed, and what the document says
Two brand switches a year
Conditions applyA supply-and-cost rule written as a clinical one. It caps how often you can move between products, whatever the reason.
“NOTE: GLP-1 medications are limited to two brand switches per year.”
Kentucky Medicaid (MedImpact clinical document) — VERSION: SEPTEMBER 2026
Six months at a time
Conditions applyEvery approval in the class runs on the same half-year clock.
“Approval Duration: 6 months”
Kentucky Medicaid (MedImpact clinical document) — VERSION: SEPTEMBER 2026
The exclusion is a footnote, repeated
Not coveredIt appears under each criteria block rather than once at the top, which is how it survives someone reading only their own drug's page.
“*Drugs used for anorexia, weight loss, or weight gain are excluded”
Kentucky Medicaid (MedImpact clinical document) — VERSION: SEPTEMBER 2026
A thyroid-cancer history bars the class
Conditions applyKentucky puts the label's boxed contraindication into the coverage criteria, so it is checked by the payer and not only the prescriber.
“No personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2”
Kentucky Medicaid (MedImpact clinical document) — VERSION: SEPTEMBER 2026
An A1c that matches the diagnosis
Conditions applyA diagnosis code alone will not do it; the number has to agree with the code.
“A1c lab value that correlates to a T2DM diagnosis”
Kentucky Medicaid (MedImpact clinical document) — VERSION: SEPTEMBER 2026
No weight-management GLP-1 on the list
Not coveredAll 2,300 non-blank lines of the September 2026 drug list were read. Wegovy, Zepbound and Saxenda appear nowhere on it, and neither do the words obesity or weight loss — while the diabetes GLP-1s are all present, which is what proves the scan works.
“Kentucky Medicaid – Preferred Drug List (PDL)”
Kentucky Medicaid (MedImpact, the single-PDL pharmacy benefit manager) — September 2026
What the state didn't publish
No GLP-1 approved for weight management appears anywhere on Kentucky's Medicaid drug list, and neither do the words obesity or weight loss.
We looked at 2300 documents to say that — All 2,300 non-blank lines of the Preferred Drug List dated September 2026, read as text end to end.
The identical scan, in the same run, over the same 2,300 lines: Ozempic 2, metformin 17, insulin 15, Mounjaro 1, Trulicity 1, Victoza 1, Rybelsus 1, liraglutide 1. The ruler finds GLP-1 brand names on this document — which is exactly the kind of token Wegovy and Zepbound are — and against those same lines Wegovy, Zepbound, Saxenda, obesity, weight loss, anti-obesity, phentermine and orlistat each returned zero.
Checked September 2026 against Kentucky Medicaid – Preferred Drug List (PDL), Kentucky Medicaid (MedImpact, the single-PDL pharmacy benefit manager).
Which of these companies serve Kentucky?
Of the 242 companies we grade, 25 publish a list of the states they are licensed in. We checked 214 more and found no such list on any page we read; 3 we have not checked either way.
18 of those lists name Kentucky: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon and Peak Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.
A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.
Sources
Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.
- Prior Authorization Criteria — Kentucky Medicaid — Kentucky Medicaid (MedImpact clinical document). Version line printed on page 1. ⛔ The URL sits under a /2023-12/ directory — the path is three years behind the paper: VERSION: SEPTEMBER 2026.
- Kentucky Medicaid – Preferred Drug List (PDL) — Kentucky Medicaid (MedImpact, the single-PDL pharmacy benefit manager). Printed directly under the title. ⛔ Same /2023-12/ path trap as the criteria document: September 2026.
Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.
If you're paying cash instead
None of the above changes what a telehealth seller charges you. 1 of these 3 bills a fee every month on top of the medication, so the figure is the two added together. The other 2 say in the cell what we could capture and what we could not. Every number was read on the seller's own page; the adding up is ours.
Lemonaid Health, Joi + Blokes and Calibrate Health pay us nothing — none of the 3 below does. The buttons run through our own redirect so we can count the click, and counting is all they do.
| Grade | Provider | What a month actually costs | The one thing that matters here | Go to the provider |
|---|---|---|---|---|
| CCaveat | Lemonaid Health | $248a month, everything billed monthly$199 compounded semaglutide microdoses + $49 a month for weight loss membershipCharged on top of the medication, which the same line says is billed separately.The lowest of the 7 medication prices we captured here | A $49 weight-loss membership with compounded semaglutide at $299, or $199 for microdoses — three separate charges to add up, which is the arithmetic a two-switch-a-year rule makes you do in advance. | See its prices at Lemonaid Health (opens in a new tab)Pays us nothing |
| CCaveat | Joi + Blokes | $187a month, medication onlycompounded nad+Medication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.$150 is the subscribe-and-save rate; $187 is the one-time purchase, which is what a single month actually costs. Both are printed on the same control.The lowest of the 4 medication prices we captured here | Compounded semaglutide at $199 and tirzepatide at $299, priced per drug rather than per plan, so switching products has a visible price. | See its prices at Joi + Blokes (opens in a new tab)Pays us nothing |
| CCaveat | Calibrate Health | No month-to-month medication price we could capture, so there is no monthly total to show.What they do bill every month: $199 a month for membership.The review says what else we found. | Charges a $199 membership and does not price the medication in it, so the switch cost and the drug cost are two different questions. | See its prices at Calibrate Health (opens in a new tab)Pays us nothing |
Our grading method and how we verify a price explain what those letters mean and where these figures came from.